Literature DB >> 7602024

Use of unproven therapies by people with Alzheimer's disease.

L M Coleman1, L L Fowler, M E Williams.   

Abstract

OBJECTIVE: To describe the use of unproven therapies for Alzheimer's disease.
DESIGN: Descriptive survey using a written questionnaire. PARTICIPANTS: 101 primary caregivers of people with Alzheimer's disease who attended Alzheimer's disease support group meetings.
RESULTS: Fifty-five percent of caregivers reported that they had tried at least one alternative therapy to improve the patient's memory. Twenty percent of caregivers tried three or more unproven therapies. Vitamins were used most frequently (84%), and health foods (27%), herbal medicines (11%), "smart pills" (9%), and home remedies (7%) were also tried. Most caregivers reported trying the therapies in the early stage of the illness and did not notice significant improvement in the patient's memory. Twenty-five percent of caregivers had tried unproven therapies for behavior problems. There was no correlation between the use of alternative therapies and the sex of the caregiver, age of the caregiver, level of caregiver frustration, presence of problem behaviors, or perceived level of physician support.
CONCLUSIONS: The use of unproven therapies by people with early Alzheimer's disease is common and cannot be predicted by characteristics of the primary caregiver. Although this use may be understandable, it exposes vulnerable people to possible side effects, increased costs, and possible exploitation. Health care workers should actively inquire about the use of alternative therapies, and explore the reasons behind their use, so that they can better understand and meet the needs of their patients and their caregivers.

Entities:  

Mesh:

Year:  1995        PMID: 7602024     DOI: 10.1111/j.1532-5415.1995.tb07043.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  7 in total

1.  The relationship between cognitive function and non-prescribed therapy use in older adults.

Authors:  Ha T Nguyen; Joseph G Grzywacz; Sara A Quandt; Rebecca H Neiberg; Wei Lang; Kathryn Altizer; Eleanor P Stoller; Ronny A Bell; Thomas A Arcury
Journal:  Aging Ment Health       Date:  2012-02-03       Impact factor: 3.658

Review 2.  Utility of nutraceutical products marketed for cognitive and memory enhancement.

Authors:  Graham J McDougall; Vonnette Austin-Wells; Teena Zimmerman
Journal:  J Holist Nurs       Date:  2005-12

3.  Electroacupuncture attenuates reference memory impairment associated with astrocytic NDRG2 suppression in APP/PS1 transgenic mice.

Authors:  Feng Wang; Haixing Zhong; Xuying Li; Ye Peng; Renee Kinden; Wei Liang; Xin Li; Ming Shi; Lixin Liu; Qiang Wang; Lize Xiong
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

4.  Mania and Psychosis Associated with St. John's Wort and Ginseng.

Authors:  Kaustubh G Joshi; Matthew D Faubion
Journal:  Psychiatry (Edgmont)       Date:  2005-09

5.  Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic.

Authors:  Julie M Dergal; Jennifer L Gold; Dara A Laxer; Monica S W Lee; Malcolm A Binns; Krista L Lanctôt; Morris Freedman; Paula A Rochon
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  Use of complementary medicine in older Americans: results from the Health and Retirement Study.

Authors:  Jose Ness; Dominic J Cirillo; David R Weir; Nicole L Nisly; Robert B Wallace
Journal:  Gerontologist       Date:  2005-08

7.  Direct and indirect risk associated with the use of dietary supplements among persons with dementia in a Norwegian memory clinic.

Authors:  Hilde Risvoll; Trude Giverhaug; Kjell H Halvorsen; Marit Waaseth; Frauke Musial
Journal:  BMC Complement Altern Med       Date:  2017-05-12       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.